Showing 121-130 of 2038 results for "".
Take Ownership of Your Career in Dry Eye
https://modernod.com/podcasts/to-the-point/take-ownership-of-your-career-in-dry-eye/36945/Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MS, MBA, FAAO, welcome their latest guest to the podcast, Pamela Theriot, OD, FAAO, who discusses her unique journey toward starting a large dry eye referral center as an associate optometrist. Dr. Theriot shares her approach to advocating for the neMaking Your Way in Dry Eye
https://modernod.com/podcasts/to-the-point/making-your-way-in-dry-eye/36935/Jennifer Shaba, OD, joins Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, on the latest episode to share her story about opening her own dry eye practice focused on regenerative medicine and holistic eye care. Dr. Shaba offers advice for optometrists at the very beginning of their oEyelash Enhancements • IPL Therapy
https://modernod.com/podcasts/the-mod-pod/eyelash-enhancements-ipl-therapy/36860/Check out the latest episode of The MOD Pod, where Cecelia Koetting, OD, FAAO, Dipl ABO, has an engaging conversation with Jason E. Compton, OD, FAAO, and Mahnia Madan, OD, FAAO, about their article on eyelash enhancements, which appears in the May/June issue Modern Optometry. In the second half of[Genetics and Eyecare Today] Common Questions Patients Ask Genetic Counselors and How to Talk to Them About Testing
https://modernod.com/podcasts/the-mod-pod/genetics-and-eyecare-today-common-questions-patients-ask-genetic-counselors-and-how-to-talk-to-them-about-testing/36809/In the latest special edition episode of The MOD Pod's mini series Genetics and Eyecare Today, the focus is on the patient. Drs. Elizabeth Yeu and Melissa Barnett speak with a genetic counselor at Avellino, who explains what to expect from a genetic counseling session and answers common questions paGlaucoma Suspects • Diagnosis and Treatment Trends • The Role of Laser in OAG • When to Add a Second Drop
https://modernod.com/podcasts/the-mod-pod/glaucoma-suspects-diagnosis-and-treatment-trends-the-role-of-laser-in-oag-when-to-add-a-second-drop/36798/First, Michael Cymbor, OD, FAAO, and Nicole Stout, OD, FAAO, walk through the steps of what to do once a patient is identified as a glaucoma suspect, then Paul Hammond, OD, FAAO, provides a rundown of the latest trends in glaucoma diagnosis and treatment. Next, Aaron McNulty, OD, FAAO, discusses theThe Truth About Generic Drugs
https://modernod.com/topics/technology/the-truth-about-generic-drugs/37920/Generic and branded drugs may be more different than you—or your patients—realize.Are Your Patients Solar Eclipse-Savvy?
https://modernod.com/articles/significant-findings/are-your-patients-solar-eclipse-savvy/37780/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatPrevalence of Keratoconus is 10x Higher Than Previously Thought
https://modernod.com/articles/significant-findings/prevalence-of-keratoconus-is-10x-higher-than-previously-thought/37745/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatB+L Receives Approval in Europe for LuxLife IOL
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-receives-approval-in-europe-for-luxlife-iol/37084/Bausch + Lomb receives CE Mark for a new full range of vision IOL; Aldeyra plans to once again resubmit a new drug application to the FDA for dry eye drug candidate reproxalap; and Topcon makes several deals to advance its AI and digital health solutions Learn more about your ad choices. Visit megAlcon Announces Plans to Acquire Lensar
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-announces-plans-to-acquire-lensar/37077/Alcon makes a major acquisition to bolster its cataract surgery portfolio; Opthea releases phase results for its combination wet AMD candidate; and Bausch + Lomb announces results from a phase 4 extension study of dry eye disease drug Miebo. Learn more about your ad choices. Visit megaphone.fm/adcho